Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics
Posted On Tuesday, April 15, 2025
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
Posted On Tuesday, April 15, 2025
Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med
Posted On Tuesday, April 15, 2025
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
Posted On Tuesday, April 15, 2025
AscellaHealth Announces Key Executive Promotions, Supporting Strategic Growth in the Life Sciences Business Unit
Posted On Tuesday, April 15, 2025
Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
Posted On Tuesday, April 15, 2025
Parexel appoints Charlotte Moser, MD, PhD, MBA as Chief Medical Officer
Posted On Tuesday, April 15, 2025
Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity
Posted On Tuesday, April 15, 2025
BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial
Posted On Tuesday, April 15, 2025
Biomerica Reports Third Quarter Fiscal 2025 Financial Results
Posted On Tuesday, April 15, 2025
Best Probiotic for Bloating and Gas 2025 - Top Probiotic Supplements for Gut Health from YourBiology
Posted On Tuesday, April 15, 2025
Ashvattha Therapeutics to Present at ARVO, Retina World Congress, and AOS Annual Meeting
Posted On Tuesday, April 15, 2025
Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates
Posted On Tuesday, April 15, 2025
RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
Posted On Tuesday, April 15, 2025
FluidForm Bio™ Advances Vascularized Tissue Engineering with New FRESH™ 3D Bioprinting Breakthrough
Posted On Tuesday, April 15, 2025
Chemomab Announces New Medical and Clinical Appointments
Posted On Tuesday, April 15, 2025
Neuphoria Provides a Review of 2024 and Highlights 2025 Plans
Posted On Tuesday, April 15, 2025
Lisata Therapeutics Announces Research License with Catalent
Posted On Tuesday, April 15, 2025
Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025
Posted On Tuesday, April 15, 2025
Aspargo Labs CEO to Participate in Panel Discussion at the American Urological Association Innovation Nexus Conference
Posted On Tuesday, April 15, 2025
Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
Posted On Tuesday, April 15, 2025
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones
Posted On Tuesday, April 15, 2025
Attovia Therapeutics Announces $90 Million Series C Financing to Advance ATTOBODY-based Programs through Clinical Proof of Concept
Posted On Tuesday, April 15, 2025
Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit
Posted On Tuesday, April 15, 2025
NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”
Posted On Monday, April 14, 2025

Print